Russian Research Institute of Hematology and Transfusiology
In research, Russian Research Institute of Hematology and Transfusiology stands highest in Medicine (#10,176 of 10,443 worldwide) and Health Sciences (#11,810 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Hematology — Hematology is 78.5× its share of world research.
- World rank, 2022–2025
- #25,947 of 28,054 · #34,084 all time
- Rank in Russia
- #885 of 1,062
- Research works
- 404 ▲ 17% vs 2013–17
- Citations
- 1.3k 3.3 per fractional work
- Top-10% rate
- 1.2% record average 16.5%
- Open access
- 58% world 28%
What is Russian Research Institute of Hematology and Transfusiology known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #10,176 of 10,443 | 1.2% | 90 | #16479 | |
| Health SciencesDomain | #11,810 of 11,982 | 1.2% | 92 | #19316 |
Each strip is that field’s whole ranked pool, with the notch where Russian Research Institute of Hematology and Transfusiology sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Russian Research Institute of Hematology and Transfusiology specialise in?
Where its research is concentrated relative to its size: Hematology takes 78.5× the share of its output that it takes of world research.
- HematologySubfield · 28.0 works79×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.9×. Every wedge is a field page.
- Immunology and Microbiology 4.9×
- Medicine 4.0×
- Pharmacology, Toxicology and Pharmaceutics 1.8×
- Biochemistry, Genetics and Molecular Biology 1.8×
- Neuroscience 0.8×
- Chemistry 0.5×
- Business, Management and Accounting 0.5×
- Health Professions 0.4×
- Nursing 0.3×
- Dentistry 0.1×
- Engineering 0.1×
- Psychology 0.1×
- Environmental Science 0.1×
- Mathematics 0.1×
- Agricultural and Biological Sciences 0.1×
- Computer Science 0.1×
- Arts and Humanities 0.0×
- Economics, Econometrics and Finance 0.0×
- Social Sciences 0.0×
Who are the top researchers at Russian Research Institute of Hematology and Transfusiology?
Ranked on the composite score, Bessmel'tsev Ss, Н. А. Романенко and Abdulkadyrov Km lead among researchers whose main affiliation is Russian Research Institute of Hematology and Transfusiology.
- 1 Bessmel'tsev Ss Russia · #846,713 worldwide 0 citations · 18 works
- 2 Н. А. Романенко Russia · #1,035,715 worldwide 2 citations · 16 works
- 3 Abdulkadyrov Km Russia · #1,146,377 worldwide 34 citations · 82 works
- 4 С. С. Бессмельцев Russia · #1,286,295 worldwide 3 citations · 23 works
- 5 А. В. Чечеткин Russia · #1,450,053 worldwide 2 citations · 23 works
- 6 Sergey Voloshin Russia · #1,516,139 worldwide 8 citations · 27 works
- 7 Vasily Shuvaev Russia · #1,541,167 worldwide 1 citations · 23 works
- 8 Irina Martynkevich Russia · #1,559,503 worldwide 1 citations · 27 works
- 9 Л. Н. Бубнова Russia · #1,565,983 worldwide 0 citations · 16 works
- 10 Mikhail Fominykh Russia · #1,572,755 worldwide 4 citations · 17 works
Which keywords describe research at Russian Research Institute of Hematology and Transfusiology?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Prognostic Factors, Mutation, Hematopoietic Stem Cells, Rituximab, BCR-ABL, Imatinib, Prognostic Scoring System and JAK2 Mutation.
- Antiviral Treatment
- Molecular Profiling
- Gene Expression Profiling
- PET Imaging
- Pathophysiology
- Classification
- SARS-CoV-2
- ACE2 Receptor
- Diagnosis
- International Myeloma Working Group
- Cancer
- Immune Response
- Genomic Aberrations
- Therapeutic Targets
- AML
- Minimal Residual Disease
- Prognostic Scoring System
- BCR-ABL
- Epidemiology
- Mutation
- Prognostic Factors
- Hematopoietic Stem Cells
- Rituximab
- Imatinib
- JAK2 Mutation
- Myelofibrosis
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Pandemic
- Proteasome Inhibitors
- Diagnosis Criteria
- Anemia
- Risk Factors
- Prophylaxis
- Thrombosis
- Mesenchymal Stem Cells
- Blood Transfusion
- Clinical Characteristics
- Lymphoma
- Hemorrhage
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Prognostic Factors16▲ 31×7 topics
- Mutation10▲ 45×3 topics
- Hematopoietic Stem Cells10▲ 93×3 topics
- Epidemiology9▲ 2.0×26 topics
- Rituximab9▲ 50×2 topics
- BCR-ABL8▲ 266×1 topic
- Imatinib8▲ 266×1 topic
- Prognostic Scoring System8▲ 165×2 topics
- JAK2 Mutation7▲ 260×1 topic
- Minimal Residual Disease7▲ 89×2 topics
- Myelofibrosis7▲ 260×1 topic
- AML7▲ 115×1 topic
- Acute Myeloid Leukemia7▲ 115×1 topic
- Therapeutic Targets6▲ 34×3 topics
- Chronic Lymphocytic Leukemia6▲ 114×1 topic
- Genomic Aberrations6▲ 114×1 topic
- Pandemic6▲ 4.6×4 topics
- Immune Response6▲ 8.4×8 topics
- Proteasome Inhibitors5▲ 64×2 topics
- Cancer5▲ 3.2×12 topics
- Diagnosis Criteria5▲ 123×1 topic
- International Myeloma Working Group5▲ 123×1 topic
- Anemia4▲ 39×4 topics
- Diagnosis4▲ 3.9×13 topics
- Risk Factors4▲ 3.3×5 topics
- ACE2 Receptor4▲ 15×2 topics
- Prophylaxis4▲ 28×4 topics
- SARS-CoV-24▲ 11×2 topics
- Thrombosis4▲ 12×4 topics
- Classification4▲ 7.3×2 topics
- Mesenchymal Stem Cells4▲ 28×2 topics
- Pathophysiology4▲ 10.0×5 topics
- Blood Transfusion3▲ 66×2 topics
- PET Imaging3▲ 17×3 topics
- Clinical Characteristics3▲ 22×2 topics
- Gene Expression Profiling3▲ 34×2 topics
- Lymphoma3▲ 18×2 topics
- Molecular Profiling3▲ 28×2 topics
- Hemorrhage3▲ 39×3 topics
- Antiviral Treatment3▲ 22×1 topic
Which research topics does Russian Research Institute of Hematology and Transfusiology publish most on?
By volume in 2022–2025: Chronic Myeloid Leukemia Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research and Chronic Lymphocytic Leukemia Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chronic Myeloid Leukemia Treatments Hematology 8 works
- 2 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 7 works
- 3 Acute Myeloid Leukemia Research Hematology 7 works
- 4 Chronic Lymphocytic Leukemia Research Genetics 6 works
- 5 Multiple Myeloma Research and Treatments Hematology 5 works
- 6 COVID-19 Clinical Research Studies Infectious Diseases 3 works
- 7 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 3 works
- 8 Hematopoietic Stem Cell Transplantation Hematology 2 works
- 9 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 2 works
- 10 Blood donation and transfusion practices Management of Technology and Innovation 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Russian Research Institute of Hematology and Transfusiology's research output changed?
Output in 2018–2022 was 17% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Saint Petersburg
- St Petersburg University
- Peter the Great St. Petersburg Polytechnic University
- ITMO University
- Ioffe Institute
- Saint Petersburg State Electrotechnical University
- Zoological Institute
- Herzen University
- First Pavlov State Medical University of St. Petersburg
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.